The Typhoid fever vaccines Marketwas valued at US$ million 262.81 in 2019and is projected to reach US$ 525.32 million by 2027; it is expected to grow at a CAGR of 9.3% from 2020 to 2027.
Typhoid is an infectious diseases caused due to contaminated food and water. Typhoid is a bacterial infection that can lead to a high fever and it is caused by the bacteria Salmonella typhi. This disease is rare in developed countries and vaccines are recommended in the areas where the disease is prevalent. There are two types of vaccines to prevent typhoid fever. One is an inactivated (killed) vaccine and the other is a live, attenuated (weakened) typhoid fever vaccine. Inactivated typhoid vaccine is administered as an injection.
The scope of the Typhoid fever vaccines market includes procedure Typhoid fever vaccines type, route of administration, and region. The market for Typhoid fever vaccinesis analyzed based on regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the Typhoid fever vaccines market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Typhoid Fever Vaccines Market: Strategic Insights
Market Size Value in US$ 262.81 million in 2019 Market Size Value by US$ 525.32 Million by 2027 Growth rate CAGR of 9.3% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Typhoid Fever Vaccines Market: Strategic Insights
| Market Size Value in | US$ 262.81 million in 2019 |
| Market Size Value by | US$ 525.32 Million by 2027 |
| Growth rate | CAGR of 9.3% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions forTyphoid fever vaccines Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Number of Patients Suffering with Typhoid
Typhoid fever refers to a systemic infection caused by Salmonella Typhi that is usually ingested through contaminated water or food. The infectious disease is usually caused predominantly in association with lack of clean water and poor sanitization. Typhoid is known to be the most common fever in rural and underdeveloped economies. According to the recent estimates of the World Health Organization (WHO), typhoid is an endemic fever in Africa, Asia, Latin America, Oceania, and the Caribbean. The WHO also states that 80% of the typhoid fever cases arise from India, Bangladesh, China, Laos, Nepal, Indonesia, Vietnam, and Pakistan. As per the recent study by All India Institute of Medical Sciences (AIIMS), around 494 per 100,000 children of age group 5–15 years suffered from typhoid in 2017.
According to the Centers for Disease Control and Prevention (CDC), most of the typhoid fever cases in the US arise among international travelers. According to a study published in Lancet: Infectious Diseases, typhoid infects ~21.6 million people worldwide and is responsible for the deaths of estimated 200,000 people each year. Further, the economic instability in Latin America and some of the other underdeveloped economies have led to improper sanitation and limited access to clean water and food, which is leading to a high risk of typhoid incidence. According to the National Health Services (NHS), children experience the highest risk of typhoid infection worldwide due to growing stage of immunity among children.
Thus, the increasing incidence of typhoid fever and high risk of transmission through contaminated food and water are likely to propel the demand for typhoid vaccines, thereby supporting the market growth over the coming years.
Typhoid fever vaccines Type-BasedInsights
Global Typhoid fever vaccines Market, based on Typhoid fever vaccines type, the Typhoid fever vaccines market is segmented into live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. In 2019, the capsular polysaccharide vaccinessegment accounted for the highest share of the market. Growth of this segment is attributed to the effectiveness associated with in preventing infectionsand increasing patient pool across the globe. The Live Attenuated Vaccine segment is likely to register highest CAGR in the global Typhoid fever vaccines market during the forecast period.
Global Typhoid fever vaccines Market, by Typhoid fever vaccines Type– 2019& 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Route of administration-BasedInsights
Global Typhoid fever vaccines Market, based on route of administration, the Typhoid fever vaccines market is segmented into oral and injections. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR of 10.1% in the market during the forecast period.
COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frighteningespecially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world’s children below the 5-year-old age group.
Product launches and expansion strategy are commonly adopted by companies to expand their footprint worldwide and meet the growing demand. These strategiesare commonly adopted by the market players in order to expand its product portfolio.
The market players operating in the Typhoid fever vaccines Market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.
By Type
- Live Attenuated Vaccine
- Capsular Polysaccharide Vaccines
- Conjugate Vaccine
- Others
By Route of Administration
- Oral
- Injections
By Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of the Europe
Asia Pacific(APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East and Africa
South America (SAM)
- Brazil
- Argentina
- Rest of South America
Company Profiles
- Shanghai institute of biological products co., ltd.
- Paxvax Inc.
- PT Bio Farma
- BIO-MED
- BHARAT BIOTECH
- Sanofi
- GlaxoSmithKline plc.
- Prokarium Ltd.
- SCANDINAVIAN BIOPHARMA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vaccine Type ; Route of administration , and Geography.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Typhoid is an infectious diseases caused due to contaminated food and water. Typhoid is a bacterial infection that can lead to a high fever and it is caused by the bacteria Salmonella typhi. This disease is rare in developed countries and vaccines are recommended in the areas where the disease is prevalent. There are two types of vaccines to prevent typhoid fever. One is an inactivated (killed) vaccine and the other is a live, attenuated (weakened) typhoid fever vaccine. Inactivated typhoid vaccine is administered as an injection.
The factors that are driving growth of the market are Growing Number of Patients Suffering with Typhoid and Organizations Supporting Typhoid Immunizations are expected to boost the growth of the global Typhoid fever vaccines market.
The Typhoid fever vaccinesmarket majorly consists of the players such as Shanghai institute of biological products co., ltd., Paxvax Inc.,PT Bio Farma, BIO-MED, BHARAT BIOTECH, Sanofi, GlaxoSmithKline plc., Prokarium Ltd., Scandinavian Biopharmaand among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Typhoid Fever Vaccines Market – By Vaccine Type
1.3.2 Typhoid Fever Vaccines Market – By Route of Administration
1.3.3 Global Typhoid Fever Vaccines Market – By Geography
2. Typhoid Fever Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Typhoid Fever Vaccines– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Typhoid Fever Vaccines Market– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Patients Suffering with Typhoid
5.1.2 Organizations Supporting Typhoid Immunizations
5.2 Market Restraint
5.2.1 Risk of Side-Effects Associated with Typhoid Fever Vaccines
5.3 Market Opportunity
5.3.1 Outsourcing Pharmaceutical Research
5.4 Future Trend
5.4.1 Development of Innovative and Potent Vaccine Candidates
5.5 Impact Analysis
6. Typhoid Fever Vaccines Market – Global Analysis
6.1 Global Typhoid Fever Vaccines Marker Revenue Forecast And Analysis
6.2 Global Typhoid Fever Vaccines Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Typhoid Fever Vaccines Market – By Vaccine Type
7.1 Overview
7.2 Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
7.3 Live Attenuated Vaccine
7.3.1 Overview
7.3.2 Live Attenuated Vaccine : Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Capsular Polysaccharide Vaccines
7.5.1 Overview
7.5.2 Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Conjugate Vaccine
7.6.1 Overview
7.6.2 Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8. Typhoid Fever Vaccines Market Analysis – By Route of Administration
8.1 Overview
8.2 Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
8.2.1 Oral
8.2.1.1 Overview
8.2.2 Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Injectable
8.3.1 Overview
8.3.2 Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9. Typhoid Fever Vaccines Market Analysis And Forecast To 2027 – Geographical Analysis
9.1 North America: Typhoid Fever Vaccines Market
9.1.1 Overview
9.1.2 North America: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.4 North America: Typhoid Fever Vaccines Market, by Route of Administration, 2018–2027 (USD Million)
9.1.5 North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
9.1.6 US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.6.3 US: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.7 Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.7.3 Canada: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.1.8 Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.1.8.3 Mexico: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.2 Europe: Typhoid Fever Vaccines Market
9.2.1 Overview
9.2.2 Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.2.4 Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.2.5 Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
9.2.6 Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.2.6.3 Germany: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.2.7 UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.2.7.3 UK: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.2.8 France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.2.8.3 France: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.2.9 Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Spain: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.2.9.3 Spain: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.2.10 Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Italy: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.2.10.3 Italy: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.2.11 Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Rest of Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.2.11.3 Rest of Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.3 Asia Pacific: Typhoid Fever Vaccines Market
9.3.1 Overview
9.3.2 Asia Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.3.4 Asia Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.3.5 Asia Pacific: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
9.3.6 China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.3.6.3 China: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.3.7 Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.3.7.3 Japan: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.3.8 India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.3.8.3 India: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.3.9 South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.3.9.3 South Korea: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.3.10 Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.3.10.3 Australia: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.3.11 Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.11.1 Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.3.11.2 Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018–2027 (USD Million)
9.3.11.3 Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018–2027 (USD Million)
9.4 Middle East and Africa: Typhoid Fever Vaccines Market
9.4.1 Overview
9.4.2 Middle East and Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East and Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
9.4.6 Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.4.6.3 Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
9.4.7 UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.4.7.3 UAE: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
9.4.8 South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.1 South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.4.8.3 South Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
9.4.9 Rest of Middle East & Africa (MEA): Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.4.9.1 Rest of MEA: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.4.9.2 Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.4.9.3 Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
9.5 South & Central America: Typhoid Fever Vaccines Market
9.5.1 Overview
9.5.2 South & Central America: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.5.4 South & Central America: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
9.5.5 South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
9.5.7 Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
9.5.8 Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.5.8.1 Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
9.5.8.2 Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
9.5.8.3 Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Shanghai institute of biological products co., ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Paxvax Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 PT Bio Farma
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BIO-MED
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BHARAT BIOTECH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sanofi
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GlaxoSmithKline plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Prokarium Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 SCANDINAVIAN BIOPHARMA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 2. North America Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 3. US Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 4. US Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 9. Europe Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 10. Europe Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. Germany Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Germany Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 13. UK Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 14. UK Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 15. France Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 16. France Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 17. Spain Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 18. Spain Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 19. Italy Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Europe Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Europe Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 23. Asia Pacific Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 24. Asia Pacific Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 25. China Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 26. China Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 27. Japan Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 28. Japan Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 29. India Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 30. India Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 33. Australia Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 34. Australia Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 35. Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 36. Rest of Asia-Pacific Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 37. Middle East & Africa: Typhoid Fever Vaccines Market, by Vaccine Type – Revenue and Forecast to 2027 (USD Million)
Table 38. Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 39. Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 40. Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 41. UAE: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 42. UAE: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 43. South Africa: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 44. South Africa: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 45. Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 46. Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 47. South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 48. South & Central America: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 49. Brazil: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 50. Brazil: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 51. Argentina: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 52. Argentina: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 55. Organic Developments Done By Companies
Table 56. Inorganic Developments Done By Companies
Table 57. Glossary of Terms, Typhoid Fever Vaccines Market
LIST OF FIGURES
Figure 1. Typhoid Fever Vaccines Market Segmentation
Figure 2. Typhoid Fever Vaccines Market – By Geography
Figure 3. Typhoid Fever Vaccines Market Overview
Figure 4. Live Attenuated Vaccine Segment Witness Fastest Growth
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Typhoid Fever Vaccines Market, by Geography (US$ Million)
Figure 7. Global Typhoid Fever Vaccines Market – Leading Country Markets (US$ Million)
Figure 8. Global Typhoid Fever Vaccines Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraint
Figure 15. Global Typhoid Fever Vaccines Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Typhoid Fever Vaccines Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Typhoid Fever Vaccines Market
Figure 18. Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
Figure 19. Live Attenuated Vaccine : Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 24. Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. North America: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 27. North America Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 28. North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
Figure 29. US: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Canada: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Mexico: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Europe: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 33. Europe Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 34. Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
Figure 35. Germany: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. UK: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. France: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. Spain: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Italy: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Rest of Europe: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. Asia Pacific: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 42. Asia Pacific Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 43. China: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 44. Japan: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. India: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. South Korea: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Australia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. Rest of Asia-Pacific: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Middle East and Africa: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 50. Middle East and Africa: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)
Figure 51. Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
Figure 52. Saudi Arabia: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. UAE: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. South Africa: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. Rest of MEA: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. South & Central America: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)
Figure 57. South & Central America: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)
Figure 58. South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
Figure 59. Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 60. Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 61. Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)
Figure 62. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in North American Countries
Figure 63. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in European Countries
Figure 64. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Asia Pacific Countries
Figure 65. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Rest of the World
Figure 66. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Typhoid Fever Vaccines Market
- Shanghai institute of biological products co., ltd.
- BHARAT BIOTECH
- Sanofi
- GlaxoSmithKline plc.
- Paxvax Inc.
- PT Bio Farma
- BIO-MED
- Prokarium Ltd.
- Scandinavian Biopharma
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Typhoid Fever Vaccines Market
Oct 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Oct 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Oct 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Oct 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)